Filing Details

Accession Number:
0001562180-20-002899
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-03 17:52:28
Reporting Period:
2020-04-01
Accepted Time:
2020-04-03 17:52:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636422 Health Catalyst Inc. HCAT Services-Computer Programming, Data Processing, Etc. (7370) 453337483
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780970 Dale Sanders C/O Health Catalyst, Inc.
3165 Millrock Drive, #400
Salt Lake City UT 84121
Chief Technology Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-01 27,500 $10.30 88,728 No 4 M Direct
Common Stock Disposition 2020-04-01 19,622 $25.56 69,106 No 4 S Direct
Common Stock Disposition 2020-04-01 7,878 $26.03 61,228 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-04-01 27,500 $0.00 27,500 $10.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,666 2019-10-28 2025-11-09 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1.
  2. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.99, inclusive.
  3. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.00 to $26.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
  4. 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019.